In conversation with the FEBS Journal, Greg discusses his early motivations, monoclonal antibody therapy research, life after the Nobel prize, and balancing entrepreneurship with science. He also lets in on a secret childhood fantasy, “As a boy I fancied being the captain of tramp steamer plying the South Pacific…”. More…
LMB In The News
Madeline Lancaster explains brain organoids to The Times
Simon Crompton of The Times interviews Madeline about her early experience when growing mini brains in the lab and the journey towards insights into human brain development and what fundamentally sets us apart from animals (story behind paywall). More…
Benjamin Falcon discusses his research in Neuronet’s first newsletter
LMB’s newly recruited Group Leader weighs in on various aspects of Alzheimer’s Disease, from the clinical implications of deciphering Tau filaments in brains of people suffering from neurodegenerative diseases, to designing precise drugs. More…
Two LMB scientists shortlisted for Cambridge Independent’s ‘Researcher of the Year’ award
This year’s Science and Technology Awards, run by Cambridge’s weekly newspaper, feature Benjamin Falcon from Neurobiology Division and Julius Fredens from Protein and Nucleic Acid Division as finalists. The ‘Researcher of the Year’ winner, out of a shortlist of six, will be announced at an awards ceremony at the Bradfield Centre. More…
What is the best time for a heart surgery?
And why does it matter? BBC writes about the role circadian rhythms plays in how our bodies respond to injuries, infections and healing, including work by John O’Neill’s group on tissue repair damage and biological time. More…
Financial Times features Madeline Lancaster in ‘Masters of Science’ 2019
How are mini brains revolutionising neuroscience? FT’s annual scientific feature series visits the LMB and Madeline’s lab to trace the rapid development in the field since 2011 when Madeline pioneered the field of cerebral organoids and insights into mechanisms of some diseases. More…